The 2023 data for blood and blood forming organs medicine sales, expressed in US Dollars PPP Per Capita, indicate that Greece leads with $151.9, followed by Belgium ($116.9) and Spain ($79.3). Noteworthy is the year-on-year variation, with Belgium (10.86%), Slovenia (9.53%), and Iceland (9.18%) showing significant growth. On the other end, Greece (-3.4%) and Slovakia (-8.36%) saw declines. The 5-year CAGR provides insights into the average annual changes, reflecting long-term performance in the market.
As we move forward, future trends to watch include emerging markets' influence on sales, innovative treatments in blood disorders, and the impact of global health policies. Additionally, advancements in biotechnology and personalized medicine are expected to drive growth in this sector.
Top countries in Blood and Blood Forming Organs Medicine Sales by Country
| # | 10 Countries | US Dollars PPP Per Capita | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Greece | 151.9 | 2023 | +3.14% | -3.4% | View data |
| 2 | 2 Belgium | 116.9 | 2023 | +8.85% | +10.86% | View data |
| 3 | 3 Spain | 79.3 | 2023 | +7.31% | +7.44% | View data |
| 4 | 4 Slovenia | 73 | 2023 | +7.2% | +9.53% | View data |
| 5 | 5 Finland | 72.9 | 2023 | +5.81% | +7.62% | View data |
| 6 | 6 Austria | 66.9 | 2023 | +5.35% | +6.21% | View data |
| 7 | 7 Iceland | 62.2 | 2023 | +1.97% | +9.18% | View data |
| 8 | 8 Portugal | 57 | 2023 | +7.14% | +8.22% | View data |
| 9 | 9 Norway | 54.8 | 2023 | +3.59% | +2.14% | View data |
| 10 | 10 Japan | 50 | 2023 | +1.83% | +7.03% | View data |
